Posted by Michael Wonder on 19 Aug 2016
HIV prevention drug Truvada won't be subsidised in Australia anytime soon
19 August 2016 - An expensive combination product that prevents people from getting HIV won't be funded by taxpayers in Australia this year.
The PBAC has rejected Gilead's submission list tenofovir disoproxil fumarate with emtricitabine (Truvada) on the PBS for the prevention of HIV (PrEP).
Truvada, a once-daily pill shown to be highly effective at preventing HIV in people at risk of getting the virus, costs about $1200 a month to buy in Australia. It can also be bought on the internet and imported into Australia for less than $100.
